RESEARCH 19. Mendonca S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M, et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and fura- zolidone in Brazil. Helicobacter. 2000;5:79–83. 20. Wang WH, Wong BC, Mukhopadhyay AK, Berg DE, Cho CH, Lai KC, et al. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong. Aliment Pharmacol Ther. 2000;14:901–10. 21. Al-Qurashi AR, El-Morsy F, Al-Quorain AA. Evolution of metron- idazole and tetracycline susceptibility pattern in Helicobacter pylori at a hospital in Saudi Arabia. Int J Antimicrob Agents. 2001;17:233–6. 22. Sharara AI, Chedid M, Araj GF, Barada KA, Mourad FH. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon. Int J Antimicrob Agents. 2002;19:155–8. 23. Kato S, Fujimura S, Udagawa H, Shimizu T, Maisawa S, Ozawa K, et al. Antibiotic resistance of Helicobacter pylori strains in Japanese children. J Clin Microbiol. 2002;40:649–53. Address for correspondence: William M. Duck, Centers for Disease Control and Prevention, Mailstop A38, 1600 Clifton Road, Atlanta, GA 30333, USA; fax: 404-639-2205; email: wdd8@cdc.gov Search past issues of EID at www.cdc.gov/eid 1094 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 6, June 2004